In this article, we will take a look at the 14 Best Biotech Stocks to Buy Right Now. The biotech industry is almost always buzzing. However, there has been some unanticipated activity in this sector ...

What you need to know about Ark Invest, an active ETF firm led by Cathie Wood that invests in disruptive, high-growth tech themes.

In addition to CRSP, ARK also made a substantial investment in Beam Therapeutics Inc (NASDAQ:BEAM), buying 491,127 shares through the ARKK ETF, amounting to over $11.2 million. This purchase aligns ...

Fintel reports that on September 18, 2025, JP Morgan initiated coverage of CRISPR Therapeutics (NasdaqGM:CRSP) with a Overweight recommendation. Analyst Price Forecast Suggests 37.35% Upside As of ...

ARK Invest isn’t letting go of its crypto conviction. Fresh filings reveal that the fund scooped another $8.2M worth of shares in crypto exchange Bullish.

Vertex faces pressure from potential U.S. drug pricing reforms and tariffs. Click here to find out why VRTX stock is a Hold.

Stanford researchers and their collaborators have revealed a new device that could change the way scientists conduct gene-editing experiments. The device, CRISPR-GPT, is an artificial intelligence lab ...

Trexquant Investment LP bought a new position in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) during the 1st quarter, according to the company in its most recent filing with the SEC.